QT
QNCX icon

Quantbot Technologies’s Quince Therapeutics QNCX Stock Holding History

Quantbot Technologies’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14
Closed -$1.78K – 1975
2022
Q4 		$1.78K Hold
14
– – ﹤0.01% 1583
2022
Q3 		$3K Sell
14
-12
-46% -$4.57K ﹤0.01% 1503
2022
Q2 		$11K Sell
26
-28
-52% -$19.8K ﹤0.01% 1520
2022
Q1 		$66K Buy
54
+53
+5,300% +$72.1K 0.01% 1139
2021
Q4 		$1K Sell
1
-1
-50% -$6.1K ﹤0.01% 1430
2021
Q3 		$45K Buy
2
+1
+100% +$15.9K ﹤0.01% 1126
2021
Q2 		$10K Hold
1
– – ﹤0.01% 1308
2021
Q1 		$7K Hold
1
– – ﹤0.01% 1277
2020
Q4 		$5K Hold
1
– – ﹤0.01% 1161
2020
Q3 		$10K Buy
+1
New +$9.1K ﹤0.01% 1117

Other funds holding QNCX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Quantbot Technologies's QNCX Position: Q1 2023 in Review

Quantbot Technologies sold out of Quince Therapeutics (QNCX) in Q1 2023, closing a stake of 14 shares — an estimated $1.78K sold.

Quantbot Technologies first reported a position in QNCX in Q3 2020 and held it in 10 quarters. The position peaked at $66K in Q1 2022. 42 funds tracked by Wall St. Rank hold QNCX as of Q1 2023.

  • Quantbot Technologies reported no remaining Quince Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 14 Quince Therapeutics shares in Q1 2023, an estimated $1.78K.
  • Quantbot Technologies first reported a position in Quince Therapeutics in Q3 2020 and held it in 10 quarters.
  • Quantbot Technologies's Quince Therapeutics position peaked at $66K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.